Tag: Chemicals and Pharmaceuticals
Allergic reactions spark flu tablet recall
Severe allergic reactions among some people have sparked a national recall of two types of cold and flu tablets. [MORE]
Dow Chemical to slash 5,000 jobs
One of the largest chemical companies in the world has announced plans to cut 5,000 jobs and close 20 plants in response to the global economic downturn. [MORE]
AMA supports chemo drug review
The Australian Medical Association (AMA) is supporting a push from pharmacy groups for the Federal Government to review the dispensing of chemotherapy drugs.[MORE]
Funding fear on cancer drugs
There are concerns the supply of drugs to cancer patients could be in jeopardy due to a federal Budget decision.[MORE]
World's biggest chemical supplier eyes off Darwin Harbour
One of the world's largest chemical suppliers says it's evaluating the potential of building a multi-billion dollar plant in Darwin Harbour.[MORE]
Court slaps Pan with $10m fine
The New South Wales District Court has fined Pan Pharmaceuticals $10 million for issuing false certificates and changing the ingredients of products exported to Vietnam. [MORE]
Pan shareholders, businesses to launch class action
Shareholders and businesses who suffered major losses during Australia's biggest drug recall are expected to announce a class action against the Commonwealth today.[MORE]
TGA investigates Gardasil-pancreatitis link
The Therapeutic Goods Administration (TGA) says it is investigating whether there is any link between the cervical cancer vaccine and pancreatic disease.[MORE]
Clinton deal to slash cost of malaria treatment
Feature
Former US president Bill Clinton has unveiled a deal to cut a key malaria drug's cost and reduce its price volatility.[MORE]
Clinton strikes deal making malaria drug cheaper
Former US president Bill Clinton has unveiled a deal with six Chinese and Indian companies to cut the price of key malaria drug artesisinin by one-third.[MORE]
Professor stumped by calls for tougher CMI regulation
A Southern Cross University (SCU) professor says he does not think the Federal Government needs to introduce tougher regulation of the complementary medicines industry (CMI).[MORE]
Gas crisis could delay float of Burrup Holdings ammonia plant
Burrup Holdings has conceded a gas explosion at Apache Energy's Varanus Island plant may delay its impending float.[MORE]
New controls considered for complementary medicines
Feature
Consumer advocates are pushing for new labelling laws for complementary medicines.[MORE]
Chemical spraying rules rile farmers
Tasmanian farmers and foresters are not happy with planned restrictions to chemical spraying.[MORE]
Work begins on hemisphere's only helium plant
Construction begins today on a new helium plant at Wickham Point in Darwin.[MORE]
$2-b fertiliser plant for Latrobe Valley
A $2-billion project to produce fertiliser from brown coal is being launched in the Latrobe Valley today.[MORE]
Pesticides found in Coal River
A southern Tasmanian river been shown to contain pesticides in the latest round of chemical testing.[MORE]
University study prompts new calls to ban herbicide
The Tasmanian Greens are calling for an immediate ban on the herbicide atrazine.[MORE]
Incitec Pivot triples first-half profit
Fertiliser manufacturer Incitec Pivot says its first-half profit has more than tripled because of a steep rise in fertiliser prices.[MORE]
NY Times reporter details pharmaceutical company marketing methods
Feature
A NY Times journo says big drug companies in the US have a two-pronged sales attack - on doctors and on consumers.[MORE]
Priceline expansion boosts API profit
An expansion of its Priceline Pharmacy business has helped deliver a half-year profit for Australian Pharmaceutical Industries (API).[MORE]
Recall sparks fears of worldwide heparin shortage
Feature
A common blood-thinning drug may have to be rationed after a contamination scare.[MORE]
Prescription-only plan amid Nurofen Plus fears
Feature
The Govt is reviewing whether some codeine-based painkillers should be available only on prescription.[MORE]
Contaminated anti-clotting drug recalled
The company which makes the anti-clotting drug Heparin says it has moved quickly to recall the contaminated products.[MORE]
Warning over contaminated anti-clotting drug
Australia's medicine watchdog has issued a safety warning over the use of an anti-clotting drug.[MORE]
